Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas

Area of Science:

• Oncology
• Molecular Pathology
• Endocrinology

Background:

• Medullary thyroid carcinomas (MTC) are rare neuroendocrine tumors originating from thyroid parafollicular C-cells.
• Approximately 20% of MTC cases are associated with inherited tumor predisposition syndromes.
• C-cell hyperplasia often serves as a precursor lesion to MTC.

Purpose of the Study:

• To investigate the role of Her2/neu oncoprotein expression in the development and aggressive behavior of MTC.
• To evaluate the correlation between Her2/neu levels and extrathyroidal extension in MTC patients.
• To compare Her2/neu expression in MTC with its precursor, C-cell hyperplasia.

Main Methods:

• Immunohistochemical analysis of Her2/neu oncoprotein levels using a specific monoclonal antibody (c-erbB-2/Her-2/neu Oncoprotein Ab-17 mAb).
• Evaluation of formalin-fixed, paraffin-embedded tissue samples from 6 MTC patients, including 5 with adjacent C-cell hyperplasia.
• Statistical analysis to determine correlations between Her2/neu expression and clinicopathological features, particularly extrathyroidal growth.

Main Results:

• A statistically significant correlation was observed between elevated Her2/neu levels and extrathyroidal growth in MTC.
• C-cell hyperplasias consistently exhibited higher levels of Her2/neu staining compared to their corresponding invasive MTCs.
• While hyperplastic areas showed large clusters of stained cells, invasive MTCs predominantly displayed single-cell reactivity.

Conclusions:

• Her2/neu oncoprotein expression significantly impacts the development and aggressive growth patterns of invasive MTC.
• Higher Her2/neu levels are strongly associated with extrathyroidal extension, indicating a more aggressive phenotype.
• Hyperplastic C-cell areas appear to play a crucial role in the pathogenesis and progression of medullary thyroid carcinoma.